Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-11-21
DOI
10.3389/fncel.2018.00440
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates NLRP3 inflammasome-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglial cells
- (2018) Ji Woong Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
- (2018) Ming-Yii Huang et al. BMC Complementary and Alternative Medicine
- Potential Use of Nanomedicine for the Anti-inflammatory Treatment of Neurodegenerative Diseases
- (2018) Maria Dolores Cayero-Otero et al. CURRENT PHARMACEUTICAL DESIGN
- Increased Oxidative Stress Exacerbates α-Synuclein Aggregation In Vivo
- (2018) Owen Scudamore et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Risk factors for non-motor symptoms in Parkinson's disease
- (2018) Johan Marinus et al. LANCET NEUROLOGY
- Author Correction: Microglial immune checkpoint mechanisms
- (2018) Aleksandra Deczkowska et al. NATURE NEUROSCIENCE
- Age affects reinforcement learning through dopamine-based learning imbalance and high decision noise—not through Parkinsonian mechanisms
- (2018) Ravi B. Sojitra et al. NEUROBIOLOGY OF AGING
- Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease
- (2018) Briana R. De Miranda et al. NEUROBIOLOGY OF DISEASE
- Helicobacter pylori infection is associated with an increased risk of Parkinson's disease: A population-based retrospective cohort study
- (2018) Huei-Kai Huang et al. PARKINSONISM & RELATED DISORDERS
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- Microglia in neurodegeneration
- (2018) Suzanne Hickman et al. NATURE NEUROSCIENCE
- Inflammasome signalling in brain function and neurodegenerative disease
- (2018) Michael T. Heneka et al. NATURE REVIEWS NEUROSCIENCE
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- NADPH oxidases in Parkinson’s disease: a systematic review
- (2017) Karim Belarbi et al. Molecular Neurodegeneration
- Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
- (2017) Nikita Katila et al. NEUROPHARMACOLOGY
- Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
- (2017) Yi-Chun Kuan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice
- (2017) Nopporn Thangthaeng et al. Aging and Disease
- AMPK Phosphorylation Modulates Pain by Activation of NLRP3 Inflammasome
- (2016) Pedro Bullón et al. ANTIOXIDANTS & REDOX SIGNALING
- Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
- (2016) Ming Lu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice
- (2016) Aiyun Li et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db / db mice
- (2016) Fang Chen et al. NEUROPHARMACOLOGY
- Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system
- (2016) Afrah A.K. Ismaiel et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- ATP-Induced Inflammasome Activation and Pyroptosis Is Regulated by AMP-Activated Protein Kinase in Macrophages
- (2016) Qing-Bing Zha et al. Frontiers in Immunology
- Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
- (2016) Jacqueline A. Bayliss et al. PLoS One
- Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
- (2015) Antonio Herrera et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages
- (2015) Beth Kelly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impaired intracellular trafficking defines early Parkinson's disease
- (2015) Benjamin H.M. Hunn et al. TRENDS IN NEUROSCIENCES
- NLRP3 Deficiency Ameliorates Neurovascular Damage in Experimental Ischemic Stroke
- (2014) Fan Yang et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Metformin attenuates blood-brain barrier disruption in mice following middle cerebral artery occlusion
- (2014) Yanqun Liu et al. Journal of Neuroinflammation
- Chronic Metformin Preconditioning Provides Neuroprotection via Suppression of NF-κB-Mediated Inflammatory Pathway in Rats with Permanent Cerebral Ischemia
- (2014) Xi-Chen Zhu et al. MOLECULAR NEUROBIOLOGY
- Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
- (2014) Mike A Nalls et al. NATURE GENETICS
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
- (2013) Sruti Rayaprolu et al. Molecular Neurodegeneration
- The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
- (2013) Eleftheria K. Pissadaki et al. Frontiers in Computational Neuroscience
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- NADPH oxidases: novel therapeutic targets for neurodegenerative diseases
- (2012) Hui-Ming Gao et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Diabetes and the Risk of Developing Parkinson's Disease in Denmark
- (2011) E. Schernhammer et al. DIABETES CARE
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- The Rate of Interleukin-1β Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering
- (2011) Sonia Carta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury
- (2010) Kenji Dohi et al. Journal of Neuroinflammation
- Case–control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
- (2010) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- Neuroinflammation in Parkinson's disease: a target for neuroprotection?
- (2009) Etienne C Hirsch et al. LANCET NEUROLOGY
- Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia
- (2009) Krzysztof Łabuzek et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus
- (2009) A.M. Espinosa-Oliva et al. NEUROBIOLOGY OF AGING
- The intranigral injection of tissue plasminogen activator induced blood–brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat
- (2009) Ruth F. Villarán et al. NEUROTOXICOLOGY
- Diabetes preceding Parkinson's disease onset. A case–control study
- (2009) Marco D'Amelio et al. PARKINSONISM & RELATED DISORDERS
- NADPH oxidase as a therapeutic target in Alzheimer's disease
- (2008) Michelle L Block BMC NEUROSCIENCE
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
- (2008) M. C. Pott Godoy et al. BRAIN
- Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
- (2008) J. A. Driver et al. DIABETES CARE
- The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery
- (2008) Garima Dutta et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Glial reactions in Parkinson's disease
- (2007) Patrick L. McGeer et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started